| pubmed-article:10746869 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10746869 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10746869 | lifeskim:mentions | umls-concept:C0024880 | lld:lifeskim |
| pubmed-article:10746869 | lifeskim:mentions | umls-concept:C0028960 | lld:lifeskim |
| pubmed-article:10746869 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:10746869 | lifeskim:mentions | umls-concept:C0058895 | lld:lifeskim |
| pubmed-article:10746869 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10746869 | pubmed:dateCreated | 2000-4-28 | lld:pubmed |
| pubmed-article:10746869 | pubmed:abstractText | The effect of mast cell blocker (ebastine) on semen quality was evaluated in 15 idiopathic oligozoospermic males. Ten milligrams/day of ebastine was administered orally for 3 months. Nine cases (66.7%) showed definite improvement in the semen quality. The wives of 3 patients (20%) became pregnant within 6 months of the initial treatment. It would appear that mast cell blocker (ebastine) significantly improves semen quality in men with idiopathic oligozoospermia. | lld:pubmed |
| pubmed-article:10746869 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10746869 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10746869 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10746869 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10746869 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10746869 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10746869 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10746869 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10746869 | pubmed:issn | 0148-5016 | lld:pubmed |
| pubmed-article:10746869 | pubmed:author | pubmed-author:SuzukiYY | lld:pubmed |
| pubmed-article:10746869 | pubmed:author | pubmed-author:HashimotoTT | lld:pubmed |
| pubmed-article:10746869 | pubmed:author | pubmed-author:HiroiMM | lld:pubmed |
| pubmed-article:10746869 | pubmed:author | pubmed-author:SaitoHH | lld:pubmed |
| pubmed-article:10746869 | pubmed:author | pubmed-author:MatsukiSS | lld:pubmed |
| pubmed-article:10746869 | pubmed:author | pubmed-author:NakadaTT | lld:pubmed |
| pubmed-article:10746869 | pubmed:author | pubmed-author:SasagawaII | lld:pubmed |
| pubmed-article:10746869 | pubmed:author | pubmed-author:YazawaHH | lld:pubmed |
| pubmed-article:10746869 | pubmed:author | pubmed-author:TatemoKK | lld:pubmed |
| pubmed-article:10746869 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10746869 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:10746869 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10746869 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10746869 | pubmed:pagination | 129-32 | lld:pubmed |
| pubmed-article:10746869 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10746869 | pubmed:meshHeading | pubmed-meshheading:10746869... | lld:pubmed |
| pubmed-article:10746869 | pubmed:meshHeading | pubmed-meshheading:10746869... | lld:pubmed |
| pubmed-article:10746869 | pubmed:meshHeading | pubmed-meshheading:10746869... | lld:pubmed |
| pubmed-article:10746869 | pubmed:meshHeading | pubmed-meshheading:10746869... | lld:pubmed |
| pubmed-article:10746869 | pubmed:meshHeading | pubmed-meshheading:10746869... | lld:pubmed |
| pubmed-article:10746869 | pubmed:meshHeading | pubmed-meshheading:10746869... | lld:pubmed |
| pubmed-article:10746869 | pubmed:meshHeading | pubmed-meshheading:10746869... | lld:pubmed |
| pubmed-article:10746869 | pubmed:meshHeading | pubmed-meshheading:10746869... | lld:pubmed |
| pubmed-article:10746869 | pubmed:meshHeading | pubmed-meshheading:10746869... | lld:pubmed |
| pubmed-article:10746869 | pubmed:articleTitle | The use of ebastine, a mast cell blocker, for treatment of oligozoospermia. | lld:pubmed |
| pubmed-article:10746869 | pubmed:affiliation | Department of Urology, Yamagata University School of Medicine, Japan. | lld:pubmed |
| pubmed-article:10746869 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10746869 | pubmed:publicationType | Clinical Trial | lld:pubmed |
